Other mechanistic studies suggest that apolipoprotein A1 itself has anti-tumorigenic properties through reduced angiogenesis, modification of immune cells, and enhancement of cholesterol efflux and reverse cholesterol transport from cancer cells; mechanisms that could potentially inhibit proliferation or growth of tumor cells [40, 41]. The gene discussed is APOA1; the disease is cancer.